SCHEMBL2408720

SCHEMBL2408720

Cc1ccccc1C(=O)OC(C)CC(C)OC(=O)c1ccccc1C

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.59
KDM4E B2RXH2 1/20 0.58
ADRB2 P07550 2/20 0.49
ADRB1 P08588 2/20 0.49
ADRB3 P13945 2/20 0.49
UTS2R Q9UKP6 1/20 0.47
ALDH1A1 P00352 3/20 0.47
TSHR P16473 2/20 0.44
SCN1A P35498 1/20 0.44
SCN2A Q99250 1/20 0.44
SCN3A Q9NY46 1/20 0.44
KMT2A Q03164 3/20 0.44
MEN1 O00255 2/20 0.44
NPC1 O15118 1/20 0.44
RAB9A P51151 1/20 0.44
USP2 O75604 1/20 0.43
MAPT P10636 1/20 0.43
ERCC5 P28715 1/20 0.42
FEN1 P39748 1/20 0.42
ESR1 P03372 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14690195 1.00 SMN1; SMN2 (0.59) SMN1; SMN2KDM4EADRB2ADRB1ADRB3
SCHEMBL13328208 0.88 SMN1; SMN2 (0.58) SMN1; SMN2KDM4EADRB2ADRB1ADRB3
SCHEMBL15110945 0.88 SMN1; SMN2 (0.58) SMN1; SMN2KDM4EADRB2ADRB1ADRB3
SCHEMBL2838593 0.86 SMN1; SMN2 (0.57) SMN1; SMN2KDM4EADRB2ADRB1ADRB3
SCHEMBL17797889 0.85 ALDH1A1 (0.62) SMN1; SMN2KDM4EADRB2ADRB1ADRB3
SCHEMBL14125173 0.84 MAPT (0.48) SMN1; SMN2KDM4EADRB2ADRB1ADRB3
SCHEMBL8995973 0.83 SMN1; SMN2 (0.54) SMN1; SMN2KDM4EADRB2ADRB1ADRB3
SCHEMBL7741930 0.83 TSHR (0.58) SMN1; SMN2KDM4EALDH1A1TSHRSCN1A
SCHEMBL1786549 0.83 SMN1; SMN2 (0.52) SMN1; SMN2KDM4EADRB2ADRB1ADRB3
SCHEMBL277670 0.83 NPC1 (0.56) SMN1; SMN2KDM4EADRB2ADRB1ADRB3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3053935-B1 CATALYST COMPOSITION FOR OLEFIN POLYMERIZATION AND APPLICATION OF SAME CHINA PETROLEUM & CHEM CORP (CN) 2019-05-08 EP claimed
US-9822196-B2 Catalyst composition for olefin polymerization and application of same CHINA PETROLEUM & CHEMICAL CORPORATION (CN) 2017-11-21 US claimed
US-20160244538-A1 CATALYST COMPOSITION FOR OLEFIN POLYMERIZATION AND APPLICATION OF SAME BEIJING RESEARCH INSTITUTE OF CHEMICAL INDUSTRY, CHINA PETROLEUM & CHEMICAL CORPORATION (CN) 2016-08-25 US claimed
EP-3053935-A1 CATALYST COMPOSITION FOR OLEFIN POLYMERIZATION AND APPLICATION OF SAME China Petroleum & Chemical Corporation (CN) 2016-08-10 EP claimed
EP-3053935-B1 CATALYST COMPOSITION FOR OLEFIN POLYMERIZATION AND APPLICATION OF SAME CHINA PETROLEUM & CHEM CORP (CN) 2019-05-08 EP disclosed
CN-109553705-A A kind of catalytic component and preparation method thereof for olefinic polymerization 中国石油化工股份有限公司 2019-04-02 CN disclosed
CN-109553711-A A kind of catalytic component and its catalyst for olefinic polymerization 中国石油化工股份有限公司 2019-04-02 CN disclosed
CN-109553708-A A kind of catalytic component and preparation method thereof for olefinic polymerization 中国石油化工股份有限公司 2019-04-02 CN disclosed
CN-109553709-A A kind of catalytic component and its catalyst for olefinic polymerization 中国石油化工股份有限公司 2019-04-02 CN disclosed
CN-109553703-A A kind of catalytic component and preparation method thereof for olefinic polymerization 中国石油化工股份有限公司 2019-04-02 CN disclosed
CN-109553712-A A kind of catalytic component and its catalyst for olefinic polymerization 中国石油化工股份有限公司 2019-04-02 CN disclosed
EP-2539378-B1 HALOGENATED AMIDE ESTER AND INTERNAL ELECTRON DONOR WITH SAME GRACE W R & CO (US) 2018-06-06 EP disclosed
EP-2539379-A1 AMIDE ESTER INTERNAL ELECTRON AND PROCESS Dow Global Technologies LLC (US) 2013-01-02 EP disclosed
EP-2539378-A1 HALOGENATED AMIDE ESTER AND INTERNAL ELECTRON DONOR WITH SAME Dow Global Technologies LLC (US) 2013-01-02 EP disclosed
US-20120322962-A1 Procatalyst Composition with Substituted Amide Ester Internal Electron Donor W. R. GRACE & CO.-CONN. 2012-12-20 US disclosed
US-20120322964-A1 Halogenated Amide Ester and Internal Electron Donor with Same DOW GLOBAL TECHNOLOGIES LLC (US) 2012-12-20 US disclosed
US-20120316299-A1 Amide Ester Internal Electron Donor and Process W. R. GRACE & CO.-CONN. 2012-12-13 US disclosed
WO-2011106500-A1 AMIDE ESTER INTERNAL ELECTRON AND PROCESS DOW GLOBAL TECHNOLOGIES LLC (US) 2011-09-01 WO disclosed
WO-2011106494-A1 PROCATALYST COMPOSITION WITH SUBSTITUTED AMIDE ESTER INTERNAL ELECTRON DONOR DOW GLOBAL TECHNOLOGIES LLC (US) 2011-09-01 WO disclosed
WO-2011106497-A1 HALOGENATED AMIDE ESTER AND INTERNAL ELECTRON DONOR WITH SAME DOW GLOBAL TECHNOLOGIES LLC (US) 2011-09-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120322964-A1 Halogenated Amide Ester and Internal Electron Donor with Same NAT10, NAT1, NAA50 SMN1; SMN2 3716/4885KDM4E 4046/4885ADRB2 2717/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.